PMID: 9376123

Berguerand M, Klapisz E, Thomas G, Humbert L, Jouniaux AM, Olivier JL, Bereziat G, Masliah J
Differential stimulation of cytosolic phospholipase A2 by bradykinin in human cystic fibrosis cell lines.
Am J Respir Cell Mol Biol. 1997 Oct;17(4):481-90., [PubMed]
Sentences
No. Mutations Sentence Comment
25 ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 9376123:25:184
status: NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Ser549Asn
X
ABCC7 p.Ser549Asn 9376123:25:174
status: NEW
view ABCC7 p.Ser549Asn details
Abbreviations: arachidonic acid, AA; cystic fibrosis, CF; cystic fibrosis transmembrane conductance regulator, CFTR; cystic fibrosis cell line presenting two minor mutations S549N and N1303K, CFT-1; cystic fibrosis cell line presenting ⌬F508 mutation, CFT-2; enhanced chemiluminescence, ECL; (1,4,5)-inositol triphosphate, IP3; normal cell line, NT-1; phospholipase A2, PLA2; phospholipase C, PLC; phenylmethylsulfonyl fluoride, PMSF; tetradecanoyl phorbol acetate, TPA. Login to comment
43 ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 9376123:43:249
status: NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 9376123:43:263
status: NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Ser549Asn
X
ABCC7 p.Ser549Asn 9376123:43:242
status: NEW
view ABCC7 p.Ser549Asn details
ABCC7 p.Ser549Asn
X
ABCC7 p.Ser549Asn 9376123:43:256
status: NEW
view ABCC7 p.Ser549Asn details
We have examined the mechanism by which the ⌬F508 CFTR mutation affects AA release by comparing the coupling of bradykinin receptors to the activation of PLC and PLA2 in a ⌬F508 tracheal epithelial cell line, a double heterozygote cell line (S549N, N1303K), and in a control cell line. Login to comment
67 ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 9376123:67:201
status: NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Ser549Asn
X
ABCC7 p.Ser549Asn 9376123:67:191
status: NEW
view ABCC7 p.Ser549Asn details
Three cell lines were studied: a control cell line (NT-1), a CF cell line carrying the homozygous mutation DF508 of CFTR (CFT-2) and a CF cell line carrying a double heterozygous mutation S549N and N1303K (CFT-1). Login to comment
68 ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 9376123:68:208
status: NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Ser549Asn
X
ABCC7 p.Ser549Asn 9376123:68:198
status: NEW
view ABCC7 p.Ser549Asn details
Three cell lines were studied: a control cell line (NT-1), a CF cell line carrying the homozygous mutation ⌬F508 of CFTR (CFT-2) and a CF cell line carrying a double heterozygous mutation S549N and N1303K (CFT-1). Login to comment
117 ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 9376123:117:325
status: NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 9376123:117:489
status: NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Ser549Asn
X
ABCC7 p.Ser549Asn 9376123:117:315
status: NEW
view ABCC7 p.Ser549Asn details
ABCC7 p.Ser549Asn
X
ABCC7 p.Ser549Asn 9376123:117:479
status: NEW
view ABCC7 p.Ser549Asn details
Results Cytosolic PLA2 Activity Specific for AA in Epithelial Cystic Fibrosis Cell Lines We have shown that an epithelial ⌬F508 cell line (CFT-2) releases more AA in response to bradykinin than do the control epithelial cell line (NT-1), or a CF epithelial cell line bearing the double heterozygous mutation S549N and N1303K (CFT-1). Login to comment
176 ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 9376123:176:110
status: NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 9376123:176:117
status: NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Ser549Asn
X
ABCC7 p.Ser549Asn 9376123:176:104
status: NEW
view ABCC7 p.Ser549Asn details
ABCC7 p.Ser549Asn
X
ABCC7 p.Ser549Asn 9376123:176:111
status: NEW
view ABCC7 p.Ser549Asn details
The maximal concentration in ⌬F508 epithelial cells was 3 times greater than in the control cells or in S549N-N1303K CF cells (Figure 5). Login to comment